Showing 1111-1120 of 10032 results for "".
AI and Skin of Color: Hidden Biases Raise Questions
https://practicaldermatology.com/topics/skin-of-color/ai-and-skin-of-color-hidden-biases-raise-questions/23994/AI holds potential for practitioners, but it’s important to think critically about what data we use to build models.Across the Lifespan: Understanding the Cutaneous Impact of Hormonal Fluctuations on Women’s Skincare
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/across-the-lifespan-understanding-the-cutaneous-impact-of-hormonal-fluctuations-on-womens-skincare/24027/Drs. Hope Mitchell, Mary Lupo, and Elizabeth Houshmand, talk with Practical Dermatology® about the unique challenges of tailoring women’s skincare to their specific needs.Cutaneous Metastasis of Adenocarcinoma with an Unknown Primary Tumor
https://practicaldermatology.com/youngmd-connect/resident-resource-center/cutaneous-metastasis-of-adenocarcinoma-with-an-unknown-primary-tumor/20352/Report and discussion: Cutaneous metastasis of adenocarcinoma with an unknown primary tumor.The Skin After Cancer
https://practicaldermatology.com/topics/general-topics/the-skin-after-cancer/20797/There are lots of questions, but still few answers. Here's what we know.Advances in Cosmeceuticals and Makeup – State of the Art from the Innovators, Part II
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-cosmeceuticals-and-makeup--state-of-the-art-from-the-innovators-part-ii/21593/Experts from different arenas in cosmetic dermatology discuss current and future developments.Diverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
https://practicaldermatology.com/issues/april-2024/il23_biologics_in_psoriasis/24457/Christopher Bunick, MD, PhD, discusses a study that explores the structural basis of IL-23 targeted biologic therapies for psoriasis. By mapping the binding sites of these therapies on the IL-23 molecule and correlating molecular properties with clinical efficacy, the study offers insights into whyTest Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.JAK Inhibitors Make the Cut for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/jak-inhibitors-make-the-cut-for-alopecia-areata/23935/JAK inhibitor approvals increase the opportunity for patients with alopecia areata to experience “life-changing” results.Colloidal Oat Wash Helps Infants with AD-prone Skin
https://practicaldermatology.com/issues/novemberdecember-2025/colloidal-oat-wash-helps-infants-with-ad-prone-skin/48896/As parents and pediatricians seek safe, science-backed skin care options for infants with atopic dermatitis (AD)-prone or reactive skin, a recent study offers clinical support for using a colloidal oat-based baby wash in the bath routine.Advances in Cosmeceuticals and Makeup – State of the Art from the Innovators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-cosmeceuticals-and-makeup--state-of-the-art-from-the-innovators/21607/Experts from different arenas in cosmetic dermatology weigh in on current and future developments.